Individuals with the GSTT1-null genotype have been shown to be at a increased risk for developing MDS [22], and polymorphisms in GSTM1 and GSTP are associated with a higher risk of developing CLL [29]. The gene discussed is GSTM1; the disease is B-cell chronic lymphocytic leukemia.